Aghayev E, Etter C, Barlocher C, et al. Five-year results of lumbar disc prostheses in the SWISSspine registry. Eur Spine J. 2014;23(10):2114-2126.
Bae HW, Kim KD, Nunley PD, et al. Comparison of Clinical Outcomes of One and Two-level Total Disc Replacement: 4-year Results from a Prospective, Randomized, Controlled, Multicenter IDE Clinical Trial. Spine (Phila Pa 1976). 2015 Jun 1;40(11):759-66.
Berg S, Tullberg T, Branth B, et al. Total disc replacement compared to lumbar fusion: a randomised controlled trial with 2-year follow-up. Eur Spine J. 2009;18(10):1512-9.
Blumenthal S, McAfee PC, Guyer RD, et al. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: Part I: Evaluation of clinical outcomes. Spine. 2005;30(14):1565-1575.
Brox JI, Sorensen R, Friis A, et al. Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration. Spine. 2003;28(17):1913-1921.
Cakir B, Schmidt R, Mattes T, et al. Index level mobility after total lumbar disc replacement: is it beneficial or detrimental? Spine. 2009;34(9):917-23.
Centers for Medicare & Medicaid Services (CMS) Medicare Coverage Advisory Committee. Spinal Fusion for the Treatment of Low Back Pain Secondary to Lumbar Degenerative Disc Disease. Transcript presented at: CMS Medicare Coverage Advisory Committee Meeting; November 30, 2006; Baltimore, MD.
Centers for Medicare & Medicaid Services (CMS). Medicare Coverage Database. Decision memo for lumbar artificial disc replacement (CAG-00292N). [CMS Web site]. May 16, 2006. Available at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=170&bc=AAAAAAAAEAAA&. Accessed September 19, 2022.
Centers for Medicare & Medicaid Services (CMS). MLN Matters. MM5727: Lumbar artificial disc replacement. [CMS Web site]. Original: 08/14/07. (Revised: 10/01/07). Available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R1340CP.pdf. Accessed September 19, 2022.
Centers for Medicare & Medicaid Services (CMS). National Coverage Determination (NCD). 150.10: Lumbar Artificial Disc Replacement (LADR). [CMS website]. 08/14/07. Available at: https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=313&ncdver=2&bc=0. Accessed September 19, 2022.
Cherkin DC, Sherman KJ, Deyo RA, Shekelle PG. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med. 2003;138(11):898-906.
Ching AC, Birkenmaier C, Hart RA. Short segment coronal plane deformity after two-level lumbar total disc replacement. Spine. 2010;35(1):44-50.
Chou R, Atlas S, Kunins L. Subacute and chronic low back pain: Surgical treatment. 06/11/2021. UpToDate website. Available at: https://www.uptodate.com/contents/subacute-and-chronic-low-back-pain-surgical-treatment#H5. Accessed August 15, 2022.
Chou R, Baisden J, Carragee EJ, et al. Surgery for low back pain: a review of the evidence for an American Pain Society Clinical Practice Guideline. Spine. 2009;34(10):1094-109.
Chou R, Loeser JD, Owens DK, et al; American Pain Society Low Back Pain Guideline Panel. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine. 2009;34(10):1066-77.
Cinotti G, David T, Postacchini F. Results of disc prosthesis after a minimum follow-up period of 2 years. Spine. 1996;21(8):995-1000.
Cui XD, Li HT, Zhang W, et al. Mid- to long-term results of total
disc replacement for lumbar degenerative disc disease: a systematic
review. J Orthop Surg Res 2018;13:326.
de Kleuver M, Oner FC, Jacobs WC. Total disc replacement for chronic low back pain: Background and a systematic review of the literature. Eur Spine J. 2003;12(2):108-116.
David T. Lumbar disc prosthesis: Surgical technique, indications and clinical results in 22 patients with a minimum of 12 months follow-up. Eur Spine J. 1993;1:254-259.
Delamarter R, Zigler JE, Balderston RA, et al. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months. J Bone Joint Surg Am. 2011;93(8):705-15.
Delamarter R, Zigler J, Goldstein J. 5-year results of the prospective, randomized, multicenter FDA investigational device exemption (IDE) ProDisc-L total disc replacement (TDR) clinical trial. Paper #3. Presented at Spine Week 2008. May 26-31, 2008. Geneva.
de Maat GH, Punt IM, van Rhijn LW, et al. Removal of the Charité lumbar artificial disc prosthesis: surgical technique. J Spinal Disord Tech. 2009; 22(5):334-9.
Deyo RA, Nachemson A, Mirza SK. Spinal-fusion surgery – the case for restraint. N Engl J Med. 2004;350(7):722-726.
Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine. 1987;12(3):264-268.
Di Silvestre M, Bakaloudis G, Lolli F, et al. Two-level total lumbar disc replacement. Eur Spine J. 2009;18(Suppl 1):64-70.
ECRI Institute. TARGET database. Artificial intervertebral disc replacement for lumbar degenerative disc disease. TARGET Report 852. May 2007.
Formica M, Divano S, Cavagnaro L, Basso, et al. L. Lumbar total disc arthroplasty: outdated surgery or here to stay procedure? A systematic review of current literature. J Orthopaed Traumatol. 2017;18(3):197-215.
Fritzell P, Berg S, Borgström F, et al. Cost effectiveness of disc prosthesis versus lumbar fusion in patients with chronic low back pain: randomized controlled trial with 2-year follow-up. Eur Spine J. 2011;20(7):1001-11.
Fritzell P, Hagg O, Wessberg P, Nordwall A; Swedish Lumbar Spine Study Group. 2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: A multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine. 2001;26(23):2521-2532.
Geisler FH, Blumenthal SL, Guyer RD, et al. Neurological complications of lumbar artificial disc replacement and comparison of clinical results with those related to lumbar arthrodesis in the literature: Results of a multicenter, prospective, randomized investigational device exemption study of Charite intervertebral disc. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine. 2004;1(2):143-154.
Gibson JN, Grant IC, Waddell G. The Cochrane review of surgery for lumbar disc prolapse and degenerative lumbar spondylosis. Spine. 1999;24(17):1820-1832.
Griffith SL, Shelokov AP, Buttner-Janz K, et al. A multicenter retrospective study of the clinical results of the LINK SB Charite intervertebral prosthesis. The initial European experience. Spine. 1994;19(16):1842-1849.
Gstoettner M, Heider D, Liebensteiner M, et al. Footprint mismatch in lumbar total disc arthroplasty. Eur Spine J. 2008;17(11):1470-5.
Guyer RD, McAfee PC, Banco RJ, et al. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the Charité artificial disc versus lumbar fusion: five-year follow-up. Spine J. 2009;9(5):374-86.
Guyer RD, Pettine K, Roh JS, et al. Comparison of 2 lumbar total disc replacements:results of a prospective, randomized, controlled, multicenter Food and Drug Administration trial with 24-month follow-up. Spine (Phila Pa 1976). 2014;39(12):925-931.
Haldeman S. Low back pain: Current physiologic concepts. Neurol Clin. 1999;17(1):1-15.
Hochschuler SH, Ohnmeiss DD, Guyer RD, Blumenthal SL. Artificial disc: Preliminary results of a prospective study in the United States. Eur Spine J. 2002;11 Suppl 2:S106-S110.
Huang RC, Sandhu HS. The current status of lumbar total disc replacement. Orthop Clin North Am. 2004;35(1):33-42.
Institute for Clinical systems Improvement (ICSI). Lumbar Artificial Intervertebral Discs [technology assessment]. December 2005.
Jacobs W, van der Gaag N, Kruyt MC, et al. Total disc replacement for chronic discogenic low back pain. Spine. 2013;38(1):24-36.
Kafer W, Clessienne CB, Daxle M, et al. Posterior component impingement after lumbar total disc replacement: a radiographic analysis of 66 ProDisc-L prostheses in 56 patients. Spine. 2008; 33(22):2444-9.
Katsimihas M, Bailey CS, Issa K, et al. Prospective clinical and radiographic results of CHARITÉ III artificial total disc arthroplasty at 2- to 7-year follow-up: a Canadian experience. Can J Surg. 2010;53(6):408-4145.
Kurtz SM, MacDonald D, Ianuzzi A, et al. The natural history of polyethylene oxidation in total disc replacement. Spine. 2009;34(22):2369-77.
Kuslich DS, Ahern JW. What tissues are responsible for low back pain and sciatica: An investigation of tissue sensitivity in humans. In: Proceedings of the Orthopedic Research Society, 40th Annual Meeting, New Orleans, LA, 1994; p110.
Laughsen LA, Paulsen RT, Carreon L et al. Patient-reported Outcomes and Revision Rates at a Mean Follow-up of 10 Years After Lumbar Total Disc Replacement. Spine. 2017 Nov 1; 42(21):1657-1663.
Leahy M, Zigler JE, Ohnmeiss DD, et al. Comparison of results of total disc replacement in postdiscectomy patients versus patients with no previous lumbar surgery. Spine. 2008; 33:1690-93.
Lebl DR, Cammisa FP, Girardi FP, et al. In vivo functional performance of failed Prodisc-L devices: retrieval analysis of lumbar total disc replacements. Spine. 2012;37(19):E1209-17.
Lee WT, Liu G, Thambiah J, et al. Clinical outcomes of single-level lumbar artificial disc replacement compared with transforaminal lumbar interbody fusion in an Asian population. Singapore Med J. 2015;56(4):208-11.
Lemaire JP, Skalli W, Lavaste F, et al. Intervertebral disc prosthesis. Results and prospects for the year 2000. Clin Orthop Relat Res. 1997;337:64-76.
Lemaire JP, Skalli W, Lavaste F, et al. Intervertebral disc prosthesis. Results and prospects for the year 2000. Clin Orthop Relat Res. 1997;337:64-76.
Markwalder TM, Wenger M, Marbacher S. A 6.5-year follow-up of 14 patients who underwent ProDisc total disc arthroplasty for combined long-standing degenerative lumbar disc disease and recent disc herniation. J Clin Neurosci. 2011;18(12):1677-81.
Mattei TA, Beer J, Teles AR, et al. Clinical outcomes of total disc replacement versus anterior lumbar interbody fusion for surgical treatment of lumbar degenerative disc disease. Global spine j. 2017;7(5):452-459.
McAfee PC. Cervical and lumbar disc replacement – the ease of revision. U.S. Orthopedics Review 2006.Available at: http://www.towsonortho.com/pdf/McAfee-edit.pdf. Accessed September 19, 2022.
McAfee PC, Cunningham B, Holsapple G, et al. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: Part II: Evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes. Spine. 2005;30(14):1576-1583.
McCrory D, Patwardhan M, Richardson W, Turner D. Spinal Fusion for Treatment of Degenerative Disease Affecting the Lumbar Spine. Agency for Healthcare Research and Quality- AHRQ Tech Assessments.2006.
Meade T, Browne W, Mellows S, et al. Comparison of chiropractic and hospital outpatient management of low back pain: A feasibility study. Report of a working group. J Epidemiol Community Health. 1986;40(1):12-17.
North American Spine Society (NASS). NASS coverage policy recommendations: Lumbar Artificial Disc Replacement. 2019. Available at: https://www.spine.org/PolicyPractice/CoverageRecommendations/AboutCoverageRecommendations. September 19, 2022.
Park CK, Ruy KS, Lee KY, et al. Clinical outcome of lumbar total disc replacement using ProDisc-L in degenerative disc disease: minimum 5-year follow-up results at a single institute. Spine. 2012;37(8):672-7.
Park CK, Ryu KS, Jee WH. Degenerative changes of discs and facet joints in lumbar total disc replacement using ProDisc II: minimum two-year follow-up. Spine. 2008;33(16):1755-61.
Park SJ, Kang KJ, Shin SK, et al. Heterotopic ossification following lumbar total disc replacement. Int Orthop. 2011;35(8):1197-201.
Pope MH, DeVocht JW. The clinical relevance of biomechanics. Neurol Clin.1999;17(1):17-41.
Punt IM, Cleutjens JP, de Bruin T, et al. Periprosthetic tissue reactions observed at revision of total intervertebral disc arthroplasty. Biomaterials. 2009;30(11):2079-84.
Punt IM, Visser VM, van Rhijn LW, et al. Complications and reoperations of the SB Charité lumbar disc prosthesis: experience in 75 patients. Eur Spine J. 2008;17(1):36-43.
Putzier M, Funk JF, Schneider SV, et al. Charite total disc replacement--clinical and radiographical results after an average follow-up of 17 years. Eur Spine J. 2006;15(2):183-95.
Roland M, Fairbank J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine. 2000;25(24):3115-3124.
Sasso RC, Foulk DM, Hahn M. Prospective, randomized trial of metal-on-metal artificial lumbar disc replacement: initial results for treatment of discogenic pain. Spine. 2008;33(2):123-31.
Schoenfeld AJ. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level degenerative lumbar disc disease. Results at twenty-four months. J Bone Joint Surg Am. 2011;93(8):e41. [Commentary.]
Siepe CJ, Heider F, Wiechert K, et al. Mid-to long-term results of total lumbar disc replacement: a prospective analysis with 5-to 10-year follow-up. 2014;14(8):1417-1431.
Siepe CJ, Zelenkov P, Sauri-Barraza JC, et al. The fate of facet joint and adjacent level disc degeneration following total lumbar disc replacement: a prospective clinical, X-ray, and magnetic resonance imaging investigation. Spine. 2010;35(22):1991-2003.
Shim CS, Lee S-H, Shin H-D, et al. CHARITEì Versus ProDisc: A Comparative Study of a Minimum 3-Year Follow-up. Spine. 2007;32(9):1012-8.
Siepe CJ, Hitzl W, Meschede P, et al. Interdependence between disc space height, range of motion and clinical outcome in total lumbar disc replacement. Spine. 2009;34(9): 904-16.
Siepe CJ, Korge A, Grochulla F, et al. Prospective, randomized trial of metal-on-metal artificial lumbar disc replacement: initial results for treatment of discogenic pain. Eur Spine J. 2008;17(1):44-56.
Siepe CJ, Tepass A, Hitzl W, et al. Dynamics of improvement following total lumbar disc replacement: is the outcome predictable? Spine. 2009;34(23): 2579-86.
Skold C, Tropp H, Berg S. Five-year follow-up of total disc replacement compared to fusion: a randomized controlled trial. Eur Spine J. 2013;22(10): 2288-95.
Sott AH, Harrison DJ. Increasing age does not affect good outcome after lumbar disc replacement. Int Orthop. 2000;24(1):50-53
.
Tropiano P, Huang RC, Girardi FP, et al. Lumbar total disc replacement. Seven to eleven-year follow-up. J Bone Joint Surg Am. 2005;87(3):490-496.
Turner JA, Ersek M, Herron L, et al. Patient outcomes after lumbar spinal fusions. JAMA. 1992;268(7):907-911.
Uschold TD, Fusco D, Germain R, et al. Cervical and Lumbar Spinal Arthroplasty: Clinical Review. Am J Neuroradiol. Am J Neuroradiol. 2012;33(9):1631-41.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. ActivL® Artificial Disc - P120024. Approval order, summary of safety and effectiveness, labeling, and other consumer information. [FDA Web site]. 06/11/2015. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf12/P120024A.pdf. Accessed September 19, 2022.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. Charité™ Artificial Disc - P040006. Approval order, summary of safety and effectiveness, labeling, and other consumer information. [FDA Web site]. 10/26/04. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P040006. Accessed September 19, 2022.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. ProDisc®-L Total Disc Replacement. Approval order, summary, labeling, and other consumer information. [FDA Web site]. 05/05/2020. Available at: https://www.fda.gov/medical-devices/recently-approved-devices/prodisc-l-total-disc-replacement-p050010s020. Accessed September 19, 2022.
van den Eerenbeemt KD, Ostelo RW, van Royen BJ, et al. Total disc replacement surgery for symptomatic degenerative lumbar disc disease: a systematic review of the literature. Eur Spine J. 2010;19(8):1262-80.
Wei J, Song Y, Sun L, et al. Comparison of artificial total disc replacement versus fusion for lumbar degenerative disc disease: a meta-analysis of randomized controlled trials. Int Orthop. 2013;37(7):1315-25.
Weinstein J, Claverie W, Gibson S. The pain of discography. Spine. 1988;13(12):1344-1348.
Yajun W, Yue Z, Xiuxin H, et al. A meta-analysis of artificial total disc replacement versus fusion for lumbar degenerative disc disease. Eur Spine J. 2010;19(8):1250-61.
Yoshizawa H, O'Brien JP, Smith WT, Trumper M. The neuropathology of intervertebral discs removed for low-back pain. J Pathol. 1980;132(2):95-104.
Zeegers WS, Bohnen LM, Laaper M, Verhaegen MJ. Artificial disc replacement with the modular type SB Charite III: 2-year results in 50 prospectively studied patients. Eur Spine J. 1999;8(3):210-217.
Zigler J, Ferko N, Cameron C, Patel L. Comparison of therapies in lumbar degenerative disc disease: a network metaanalysis of randomized controlled trials. J compar effectiv res. 2018;7(3):233-246.
Zigler J, Gornet MF, Ferko N, et al. Comparison of lumbar total disc replacement with surgical spinal fusion for the treatment of single-level degenerative disc disease: a meta-analysis of 5-year outcomes from randomized controlled trials. Global Spine J. 2018;8(4):413-423.
Zigler, JE, Blumenthal, SL, Guyer, RD, Ohnmeiss, DD, and Patel, L. Progression of adjacent-level degeneration after lumbar total disc replacement: results of a post-hoc analysis of patients with available radiographs from a prospective study with 5-year follow-up. Spine. 2018. [Epub ahead of print].
Zigler JE, Delamarter RB, Spivak JM, et al. Results of the prospective, randomized, multi-center FDA investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of one level degenerative disc disease. Spine. 2007;32(11):1155-1162.
Zigler JE, Delamarter RB, Spivak JM, et al. Results of the prospective, randomized, multi-center FDA investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of one level degenerative disc disease. Spine. 2007;32(11):1155-1162.